NDC 69367-251 - WesNatal DHA Complete
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69367-251
- Package NDCs from labels
- 69367-251-30
- Manufacturer
- Westminster Pharmaceuticals, LLC
- Effective date
- 2026-05-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| WesNatal DHA Complete - Westminster Pharmaceuticals, LLC | Westminster Pharmaceuticals, LLC | 2026-05-22 | DIETARY SUPPLEMENT |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69367-251-30 | WesNatal DHA Complete | 1 in 1 CARTON | KIT | 1 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69367-251-30 | EA - Each | 69367-251 | 53277372-04d2-43b2-b6bc-11548fa09ee6 | 1 | 2023-05-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| XYCOS PINK COLLAGEN SERUM | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a22d3cad-f8e7-7339-e053-2a95a90af8a4 | 2020-03-31 | Warnings | 25X51I8RD4 |
| XYCOS PINK COLLAGEN TONER | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a22d5d31-4c3f-651c-e053-2a95a90ae541 | 2020-03-31 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE ROSE HEAVEN | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21c097c-82ac-3a21-e053-2995a90a63eb | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Rose HeavenCream | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21ba34c-2d2d-8033-e053-2995a90a1d74 | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE ROSE HEAVEN SERUM | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21c72f8-00ff-0971-e053-2995a90a2f97 | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Vital BrightCream | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21cbf42-482c-2d95-e053-2a95a90a1a48 | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Vital Bright Emulsion | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21d0eba-a96c-72e8-e053-2995a90addfb | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Vital Bright EyeCream | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21d3c87-0a7f-2e15-e053-2a95a90aee69 | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Vital BrightSerum | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21d8184-258f-679e-e053-2995a90ad7c4 | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Vital Bright Toner | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21daae8-98d6-203a-e053-2a95a90aafe5 | 2020-03-30 | Warnings | 25X51I8RD4 |
| Dextrose | DEXTROSE MONOHYDRATE | Baxter Healthcare Company | 7de48bdb-9a05-4f2a-bbff-dcfeb284ca6e | 2020-02-27 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose and Electrolyte No. 48 | SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, MONOBASIC POTASSIUM PHOSPHATE, SODIUM CHLORIDE AND DEXTROSE MONOHYDRATE | Baxter Healthcare Company | b283a454-0c20-4fbf-92d3-dae1f3cd3cad | 2020-02-13 | Warnings, Adverse reactions | LX22YL083G |
| Thinksport Sunscreen SPF 18 | ZINC OXIDE | thinkOperations,LLC | 9cd5010c-0b23-2888-e053-2995a90adb72 | 2020-01-23 | Warnings | SOI2LOH54Z |
| Sterile Water | WATER | Baxter Healthcare Company | 8bcf5572-49e1-4302-9522-56f57904cb4a | 2019-12-29 | Warnings, Adverse reactions | 059QF0KO0R |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | e41adb4e-06fb-4141-ba55-50b043f3c9da | 2019-11-19 | LX22YL083G | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 14445dfd-6041-40cd-a043-3f4da6bcb9c1 | 2019-11-18 | LX22YL083G | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 2557199a-5f60-49d8-b093-1e0700211243 | 2019-11-18 | LX22YL083G | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 794f724c-87f0-49c1-9b26-c9e491978313 | 2019-11-18 | LX22YL083G | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 5c7d3287-883a-459b-9214-074a583c8a59 | 2019-11-18 | LX22YL083G | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 448a1dc5-7a98-4b2f-82af-4b92de05cfc3 | 2019-11-18 | LX22YL083G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.